188 related articles for article (PubMed ID: 37085672)
21. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition.
Fernández-Marcelo T; Morán A; de Juan C; Pascua I; Head J; Gómez A; Hernando F; López-Asenjo JA; Hernández S; Sánchez-Pernaute A; Torres AJ; Benito M; Iniesta P
Oncology; 2012; 82(3):153-64. PubMed ID: 22433385
[TBL] [Abstract][Full Text] [Related]
22. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
[TBL] [Abstract][Full Text] [Related]
23. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
24. Functional polymorphisms on chromosome 5p15.33 disturb telomere biology and confer the risk of non-small cell lung cancer in Chinese population.
Li Y; Xiang C; Shen N; Deng L; Luo X; Yuan P; Ji Z; Li J; Cheng L
Mol Carcinog; 2019 Jun; 58(6):913-921. PubMed ID: 30680798
[TBL] [Abstract][Full Text] [Related]
25. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
Redin E; Garmendia I; Lozano T; Serrano D; Senent Y; Redrado M; Villalba M; De Andrea CE; Exposito F; Ajona D; Ortiz-Espinosa S; Remirez A; Bertolo C; Sainz C; Garcia-Pedrero J; Pio R; Lasarte J; Agorreta J; Montuenga LM; Calvo A
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33658304
[TBL] [Abstract][Full Text] [Related]
26. AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.
Muñoz-Lorente MA; Martínez P; Tejera Á; Whittemore K; Moisés-Silva AC; Bosch F; Blasco MA
PLoS Genet; 2018 Aug; 14(8):e1007562. PubMed ID: 30114189
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Liu Z; Huang JA
Oncotarget; 2017 May; 8(19):30817-30829. PubMed ID: 28199217
[TBL] [Abstract][Full Text] [Related]
28. FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway.
Sun CC; Zhu W; Li SJ; Hu W; Zhang J; Zhuo Y; Zhang H; Wang J; Zhang Y; Huang SX; He QQ; Li DJ
Genome Med; 2020 Sep; 12(1):77. PubMed ID: 32878637
[TBL] [Abstract][Full Text] [Related]
29. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
Pantic M; Zimmermann S; Waller CF; Martens UM
Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
[TBL] [Abstract][Full Text] [Related]
30. Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.
Juncheng P; Joseph A; Lafarge A; Martins I; Obrist F; Pol J; Saavedra E; Li S; Sauvat A; Cerrato G; Lévesque S; Leduc M; Kepp O; Durand S; Aprahamian F; Nirmalathansan N; Michels J; Kroemer G; Castedo M
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35772809
[TBL] [Abstract][Full Text] [Related]
31. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
32. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
33. Telomerase promotes formation of a telomere protective complex in cancer cells.
Perera ON; Sobinoff AP; Teber ET; Harman A; Maritz MF; Yang SF; Pickett HA; Cesare AJ; Arthur JW; MacKenzie KL; Bryan TM
Sci Adv; 2019 Oct; 5(10):eaav4409. PubMed ID: 31616780
[TBL] [Abstract][Full Text] [Related]
34. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status.
Fernández-Marcelo T; Gómez A; Pascua I; de Juan C; Head J; Hernando F; Jarabo JR; Calatayud J; Torres-García AJ; Iniesta P
J Exp Clin Cancer Res; 2015 Aug; 34(1):78. PubMed ID: 26250468
[TBL] [Abstract][Full Text] [Related]
35. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.
Wang W; Li L; Zhao L
J Cell Mol Med; 2021 Nov; 25(21):9927-9938. PubMed ID: 34651416
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
[TBL] [Abstract][Full Text] [Related]
37. Icariside II potentiates the anti-PD-1 antitumor effect by reducing chemotactic infiltration of myeloid-derived suppressor cells into the tumor microenvironment via ROS-mediated inactivation of the SRC/ERK/STAT3 signaling pathways.
Kong Q; Ma M; Zhang L; Liu S; He S; Wu J; Liu B; Dong J
Phytomedicine; 2023 Feb; 110():154638. PubMed ID: 36621167
[TBL] [Abstract][Full Text] [Related]
38. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
39. Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer.
Fu J; Wang X; Yue Q
Biochem Biophys Res Commun; 2020 Sep; 529(4):1086-1093. PubMed ID: 32819569
[TBL] [Abstract][Full Text] [Related]
40. Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXR
You W; Li L; Sun D; Liu X; Xia Z; Xue S; Chen B; Qin H; Ai J; Jiang H
Cancer Immunol Res; 2019 Jun; 7(6):990-1000. PubMed ID: 30975694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
